Rob Lown retweeted
A new trial to improve treatment for severe lupus is being led by @uclh colleagues.
Using CAR-T therapy to modify the immune system to target unhealthy cells, the trial could reduce, or even remove, the need for lifelong medication for severe lupus. uclh.nhs.uk/news/uclh-announ…
Rob Lown retweeted
So promising..& privilege to lead in 🇬🇧 & 🇪🇸
‘TRBC1-CAR T cell therapy in PTCL: a phase 1/2 trial’
Co-I @gloria_iacoboni #ETholouli @tobiasmenne2 #DIrvine
Huge science credit to #MartinPule @paulmaciocia #MatFerrari #TeresaMarafioti et al
#Autolus
@NatureMedicine @uclcancer
The AUTO4/librat1 trial has published results from initial 10 patients with PTCL treated with anti-TRBC1 CAR-T cells. Headline results: 40% CR including 2 in remission beyond 2 years, 3/4 CRs at highest dose. 1/ nature.com/articles/s41591-0…
Rob Lown retweeted
📺 In the spotlight: Allan's remarkable recovery with CAR T-cell therapy at UHS. 🏥
This week, former Royal bodyguard, Allan Peters' inspiring journey from 'terminal' cancer to full remission has been making headlines in local media and on national TV.
🧵(1/3) 👇
Strava gives a nice example of why ‘I can still do a round of golf’ is a good marker of fitness. 4.5hrs on one’s feet over 10k distance is no mean feat!
1
184
Rob Lown retweeted
A woman from Hampshire who was diagnosed with cancer and spent weeks in a coma while pregnant has celebrated the birth of her daughter.
itv.com/news/meridian/2024-0…
Rob Lown retweeted
An incredible story. 👇
Beth faced a diagnosis of Hodgkin Lymphoma complicated by encephalopathy causing her to be unconscious for the first few months of pregnancy.
Last week, Beth visited our @UHS_lymphoma service with the lovely Isabella. 💕🌟
🔗 bbc.co.uk/news/articles/cd17…
Rob Lown retweeted
I’m extremely excited to be running the London Marathon next year for a charity close to my heart - Lymphoma Action. I would be grateful if you could spare 5 minutes to clink on this link and read more about the amazing charity and why it’s important to me
justgiving.com/page/polly-pa…
Rob Lown retweeted
Obe-cel (AUTO1), a CD19/41BB CAR-T cell therapy, shows fantastic results in relapsed/refractory B-cell acute lymphoblastic leukemia (B-ALL) in the Phase II FELIX trial. #CART
WELL DONE @drclaireroddie and team
ascopubs.org/doi/abs/10.1200…
Rob Lown retweeted
This is such a powerful regimen. 94% 4y PFS is incredible. In places thay use escBEACOPP (& which fund it) this will be the new standard. The question is how far it will extend into ABVD / AVD-N using areas.
US colleagues - will you use it do you think?
Rob Lown retweeted
Exciting opportunity to join the brilliant @WessexBMTCT @robertlown @PWMJohnson @SeanHuaLim #CAR-T fellowship careers.uhs.nhs.uk/job-descr…
Come work with a fab, friendly and forward-looking lymphoma team. Working with renowned experts @AndyD1036, @PWMJohnson, @SeanHuaLim. Plus working with UK myeloma expert @JennerMatthew and top transplant unit @WessexBMTCT.
jobs.nhs.uk/candidate/jobadv…
Rob Lown retweeted
free access, bmj
why the fuss about PAs?
bmj.com/content/385/bmj.q862
Rob Lown retweeted
Glioblastoma is the most formidable of primary brain tumors, owing to its aggressive nature and the limited efficacy of the best available treatment.
Science behind the Study: nej.md/49yGoKf 1/12
#Oncology





















